QUOTE(Takudan @ Jan 26 2022, 12:56 PM)
Ooh.
I bought Nestle haha. Truth be told I thought of this very simply. I wanted to diversify into food related stocks, and I looked around, I just thought, yeah I like Nestlé products, all hail Milo! Didn't want Bursa, noticed Swiss has tax treaty with Malaysia, so I went with that. At that time, I didn't know I had to mail in the tax voucher thingy to actually enjoy the tax treaty.
Honestly never heard of the others, but yeah since I'm getting CHF as dividends, I was wondering if I should pick up more Swiss stocks... The "dividend reinvestment" option isn't working for me, I am assuming that is because my dividend amount wasn't enough to get a full share and fractional share isn't available outside US for IBKR.. I do remember however, that I had to convert currency twice from SGD to CHF, so it's also a little off putting...
How much do you plan to invest (or already is) in Swiss? In terms of your portfolio %, if you don't mind..
lol Nestle yes. What was your average price?
Nestle, Roche and Novartis together account for 50% of SMI index
https://en.wikipedia.org/wiki/Swiss_Market_Index (each account for 17% weighting).
Roche is a well-known big pharma stock, second only to JNJ. It is well-known for its unusual corporate structure, where the Roche family control 18-20% of shares but have large voting rights of 50% or more. So there are 2 shares, RO (with higher voting rights, but with low liquidity since majority are held by the Roche family) and ROG (no voting rights, but more liquid). ROG (34x ++) is cheaper than RO (39x ++) as people value the rights to vote. As a return for the "stripped" voting rights, the Roche family has kept the balance sheet of the company in very good shape, their net debt is just a few months of earnings and AA3 rated, similar in level to Nestle.
https://wikirating.org/list-of-corporations...-credit-rating/ Novartis balance sheet a bit worse than Nestle and Roche (A-range rating), but I like their generic drug division, Sandoz for revenue diversification (barring their price fixing litigation issue). Roche and Nestle both has a Level I ADR in US, but they can only be traded OTC (they don't file 20-F) and I can't buy them on IBKR even after checking all US trading permissions. Novartis has a Level II ADR that trades actively on NYSE however.
As for fractional shares, I remember I saw fractional shares options in the drop down box, you can see the screenshot below:

I have not tried them though.
Another suggestion for dividend reinvestment is since Novartis share price is very low compared to Roche and Nestle, you can use the dividends earned from Nestle and Novartis to buy Novartis, if the amount is not too small. Novartis share price is around 7x CHF, compared to Roche 34x and Nestle 11x. Otherwise, you can look at the SMI Index list (link above) and see if you can find other counters to buy. UBS, Zurich Insurance, ABB, Alcon etc. In the worst case, just keep the CHF and it will appreciate vs MYR over the long run.
Regarding conversion, I have shown that you can use Wise multicurrency account to fund CHF in IBKR, you can try that too (keep the fund origination document as proof though).
As for investment portion, 3 counters should account for around 7-10% of a 30-40 stock portfolio, but as keep adding other shares into it, can expect that number to drop further to 3-5% over time. Now queuing for ROG and NESN.